A novel modified PAIR technique using a trocar catheter for percutaneous treatment of liver hydatid cysts: a six-year experience

PURPOSE

We aimed to demonstrate the success and reliability of a novel puncture, aspiration, injection, and reaspiration (PAIR) technique in liver hydatid cysts.

METHODS

Percutaneous treatment with ultrasonographic guidance was performed in 493 hepatic hydatid cysts in 374 patients. Patients were treated with a new PAIR technique by single puncture method using a 6F trocar catheter. The results of this novel technique were evaluated with regards to efficacy and safety of the procedure and complication rates.

RESULTS

Out of 493 cysts, 317 were Gharbi type I (WHO CE 1) and 176 were Gharbi type II (WHO CE 3A). Of all cysts, 13 were referred to surgery because of cystobiliary fistulization. Recurrence was observed in 11 cysts one month later. Therefore, the success rate of the PAIR technique was 97.7% (469/480). Minor complications (fever, urticaria-like reactions, biliary fistula) were seen in 44 treated patients (12%, 44/374); the only major complication was reversible anaphylactic shock which was observed in two patients (0.5%, 2/374).

CONCLUSION

This novel modified PAIR technique may be superior to catheterization by Seldinger technique due to its efficiency, easier application, lower severe complication rate, and lower cost. Further comparative studies are required to confirm our observations.Hydatid disease is a parasitic infection caused by the larval stage of the tapeworm Echinococcus. E. granulosus is the most common cause of hydatid disease in humans and is found throughout the world. It is endemic in large sheep raising areas like the Mediterranean region, the Middle East, Southeast and Central Russia, Northern China, South America, Australia, and New Zealand (1). Hydatid disease usually affects the liver (50%–70%) and less frequently lung, peritoneum, kidney, brain, mediastinum, heart, bone, soft tissues, spinal cord, spleen, pleura, adrenal glands, bladder, ovary, scrotum, and thyroid gland (2). Treatment approaches include medical, surgical, and minimally invasive procedures. Medical treatment with albendazole or mebendazole alone has a low rate of success and high rate of relapse, making this treatment option controversial (3). The surgical approach has been the gold standard therapy for the hydatid disease for a long time (4). However, in recent years, percutaneous treatment of the hydatid cyst emerged as a potential alternative to surgery, because of its efficiency, reliability, and low morbidity and mortality rates. The puncture, aspiration, injection, and reaspiration (PAIR) technique, which involves puncture of the cyst wall, aspiration of cyst contents, instillation, and reaspiration of the scolicidal agent, has gained international recognition. PAIR technique can be achieved by using a coaxial catheter system to aspirate the cyst content and infuse scolicidal agent at the same time (5). Another technique can be performed by catheterization (3, 6). In our study, we performed the PAIR procedure by directly entering into the hydatid cyst cavity through a single puncture using a trocar catheter instead of placing a catheter through stiff wire after puncturing with a Seldinger needle. The primary goal of the current study was to determine the success and reliability of this technique in patients with hydatid disease.     

Primed Mesenchymal Stem Cells Alter and Improve Rat Medial Collateral Ligament Healing

Cell therapy with mesenchymal stem cells (MSCs) can improve tissue healing. It is possible, however, that priming MSCs prior to implantation can further enhance their therapeutic benefit. This study was then performed to test whether priming MSCs to be more anti-inflammatory would enhance healing in a rat ligament model, i.e. a medial collateral ligament (MCL). MSCs were primed for 48 h using polyinosinic acid and polycytidylic acid (Poly (I:C)) at a concentration of 1 μg/ml. Rat MCLs were surgically transected and administered 1?×?10⁶ cells in a carrier solution at the time of injury. A series of healing metrics were analyzed at days 4 and 14 post-injury in the ligaments that received primed MSCs, unprimed MSCs, or no cells (controls). Applying primed MSCs beneficially altered healing by affecting endothelialization, type 2 macrophage presence, apoptosis, procollagen 1α, and IL-1Ra levels. When analyzing MSC localization, both primed and unprimed MSCs co-localized with endothelial cells and pericytes suggesting a supportive role in angiogenesis. Priming MSCs prior to implantation altered key ligament healing events, resulted in a more anti-inflammatory environment, and improved healing.     

Small cell carcinoma of the urinary bladder: changing trends in the current literature

Background Extrapulmonary small cell carcinoma (SmCC), also known as oat cell carcinoma or small cell neuroendocrine carcinoma, is characterized by an aggressive clinical course with early metastasis pattern and a short life expectancy. So far, there is no prospective, data-based case–control study due to its low incidence. The purpose of this paper is to discuss the epidemiology, morphopathology, clinical characteristics, differential diagnosis and treatment of bladder SmCC in the light of the literature.

Scope PubMed and American Society of Clinical Oncology Meeting abstracts were searched according to the following keywords: ‘extrapulmonary SmCC’, ‘bladder cancer’, and ‘therapeutic approach’. The last search was performed on 1 October 2015. Some additional papers were determined by reviewing references of the appropriate articles. Most of the data regarding small cell carcinoma of the urinary bladder (SmCCB) were found to be based on the retrospective trials.

Findings Bladder SmCC is more frequent in men and usually appears in the seventh to eighth decades. Macroscopic hematuria is the most common clinical symptom. The diagnosis of SmCCB is performed based on the same criteria determined by the WHO classification for the diagnosis of small cell lung carcinoma (SCLC). Prognosis is closely correlated with the stage at presentation. Although the prognosis of the disease is poor, a long survival can be achieved particularly by radical surgery following neoadjuvant chemotherapy in patients with early stage tumors. Cystectomy is still the current standard local treatment. However, cystectomy alone is not sufficient. Chemotherapy and definitive radiotherapy should be preferred for limited disease in patients who are not candidate for surgery.

Conclusion Considering the poor prognosis of the disease, further studies are needed to determine the optimal treatment options and new molecular markers in the way of early diagnosis and favorable outcomes. Prospective, multicenter, randomized studies are required to evaluate the role of neoadjuvant chemotherapy followed either by surgery or radiotherapy.     

Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables.

We investigated the relation of expression of tumor-suppressor gene product p53, apoptosis-regulator gene product bcl-2, and CD34 (as a measure of microvessel density [MVD]) with traditional clinicopathologic prognostic variables in endometrial carcinoma (histologic type, grade, depth of myometrial invasion, angiolymphatic invasion, lymph node involvement). In specimens from 63 patients with endometrial carcinoma, the mean MVD (64.38+/-28.71 microvessels per 200x field) was not related to any clinicopathologic variables. Nuclear p53 expression was detected in 15 (23.8%) patients and was higher in nonendometrioid carcinomas (p<0.05) and in tumors with increasing histologic grade (p<0.001). Cytoplasmic bcl-2 staining was seen in 79.3% of the tumors. There was a negative correlation between bcl-2 expression and histologic type and tumor grade (p<0.05). In survival analysis, patient age, FIGO stage, high expression of p53, low expression of bcl-2, and high and intermediate MVD values were found to be the most significant prognostic indicators of survival (p<0.05). In multivariate regression analysis, FIGO stage and low bcl-2 expression were found to be the only independent indicators of prognosis (p<0.05).     

Identification of yeasts in public hospital primary care patients with or without clinical vaginitis

OBJECTIVE: Vaginal yeast infections are one of the most common female genital tract infections. Candida albicans is the most common infectious cause. Candida species other than C. albicans are being diagnosed with increasing frequency. The aim of the present study was to determine species of yeasts obtained from the vaginal fluid among public hospital primary care patients with or without clinical vaginitis and to evaluate the correlation of vaginal yeast colonisation with epidemiological and clinical features of applicants. METHODS: Vaginal swabs from 622 women who underwent vaginal examination in a women's hospital were obtained. After isolation, identification tests were carried out on 106 yeast species. Epidemiological and clinical features of women with respect to these species were evaluated. RESULTS: Of 106 yeasts isolated, 67 C. albicans, 10 C. glabrata, seven C. kefyr (pseudotropicalis), six C. tropicalis, five C. parapsilosis, five C. krusei, three Saccharomyces boulardii, one C. guillermondii, one S. cerevisiae and one Trichosporon species were identified as yeast subtypes. Of the women with C. albicans, C. glabrata, C. kefyr, C. tropicalis, C. krusei, 60, three, one, one, and one, respectively, had symptoms of vaginitis. Of women with C. albicans, C. glabrata, C. kefyr, C. tropicalis, C. parapsilosis, C. krusei, and the other species, 27, four, three, two, one, one, and one, respectively, had clinical findings of vaginitis. CONCLUSION: Despite the heterogeneity of the present study group, the results support the use of vaginal culture as the most sensitive test for final diagnosis. However, a positive culture does not mean that the C. albicans is pathogenic, as it may be the normal commensal pathogen. Correlation of clinical and laboratory findings is important as it enables the administration of appropriate treatment without delay.